KALARIS THERAPEUTICS, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
KALARIS THERAPEUTICS, INC. (KLRS) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$43.44 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-17
- KALARIS THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$43.44M.
- KALARIS THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$69.17M.
- KALARIS THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$376.15M.
- KALARIS THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$113.39M, a 331.19% decline from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$43.44M 10-K · filed 2026-03-17 | |
| 2024-12-31 | -$69.17M 10-K · filed 2026-03-17 | -$57.12M 10-K · filed 2025-03-07 |
| 2023-12-31 | -$376.15M 10-K · filed 2025-03-07 | |
| 2022-12-31 | -$113.39M 10-K · filed 2024-03-15 | |
| 2021-12-31 | $49.05M 10-K · filed 2023-02-15 | |
| 2020-12-31 | -$68.36M 10-K · filed 2022-02-10 | |
| 2019-12-31 | -$23.84M 10-K · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |